https://cdnimg.rg.ru/img/content/192/21/99/photorep_imageid_554588_06e1c4987d16d9f1590735021_d_850.jpg

According to the chief of the 48th Central research Institute of the troops of NBC protection of the Armed Forces of the Russian Federation of the Colonel of a health service Sergey Borisevich, clinical trials of the Russian vaccine against coronavirus, developed jointly by the Ministry of defence of the Russian Federation National research center of epidemiology and Microbiology them. academician N. F.Gamalei, in hospital Burdenko thus completed.

In this case, scientists, in his words, there is still a huge reservoir of analytical work. It and produce a final report and presentation of results, and the state registration of the vaccine product. “But the data analyses now confirm that as a result of vaccination in volunteers revealed the necessary antibodies to coronavirus. And the components of the vaccine safe and well tolerated person”, – quotes the newspaper “Red star” Colonel Borisevich.

it is Noted that the patented inventions, scientific achievements and experience of staff of the 48th Central research Institute of the troops of NBC protection have helped to significantly reduce the time preclinical evaluation of safety and efficacy of the vaccine from COVID-19.

In particular, according to the military physicians during pre-clinical vaccine trials to assess the protective efficacy of medicines was used that was developed in the 48th Central research Institute methodology of a quantitative estimation of the pathogen, and laboratory model that allows to reproduce the course of severe acute respiratory disease (SARS-CoV).

“the Capabilities of the platform on which this was developed two vaccines against Ebola and a vaccine against middle East respiratory syndrome, will allow for a long time to maintain a protective titer produced after immunization”, – said the head of the 48th Central research Institute of troops NBC-defense.

the defense Ministry recalled that the 48th research Institute has tremendous experience in the evaluation of the protective efficacy of medicines. So, for almost 80 years of its existence the Institute “issued a” state of dozens of vaccines. And they not only actively used in the past, but continue to be used in the present, for example, plague, anthrax and smallpox vaccine.